NCT06220032 2026-01-05
HO170DLBCL
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3 Recruiting
Clinical Trials
9 trialsNCT02916316 2025-11-18
Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell
Fondazione Italiana Linfomi - ETS
Completed
NCT06155331 2025-08-19
Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients
Tanta University
Phase 2 Completed
NCT00436566 2022-08-05
Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery
Mayo Clinic
Phase 2 Completed
NCT00875238 2018-02-19
PACE in BC
Vanderbilt University Medical Center
Completed
NCT01120171 2015-10-07
Myocet Plus Endoxan for Older Patients With Breast Cancer
Hellenic Oncology Research Group
Phase 2 Terminated
NCT00377559 2015-10-06
MYOTAX
Catharina Ziekenhuis Eindhoven
Phase 2 Completed
NCT00377780 2015-09-23
MYOHERTAX
Catharina Ziekenhuis Eindhoven
Phase 2 Terminated
NCT01095926 2013-06-28
Doxo
University Hospital Muenster
Phase 2 Completed